GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 85 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,378,000 | +364.0% | 20,234 | +117.5% | 0.01% | +400.0% |
| Q2 2022 | $297,000 | -28.8% | 9,303 | -22.6% | 0.00% | 0.0% |
| Q1 2022 | $417,000 | +32.4% | 12,024 | +11.6% | 0.00% | +100.0% |
| Q4 2021 | $315,000 | +37.6% | 10,775 | +19.7% | 0.00% | 0.0% |
| Q3 2021 | $229,000 | -10.2% | 9,002 | +23.4% | 0.00% | 0.0% |
| Q2 2021 | $255,000 | +0.8% | 7,293 | +17.6% | 0.00% | 0.0% |
| Q1 2021 | $253,000 | +15.0% | 6,204 | +22.3% | 0.00% | 0.0% |
| Q4 2020 | $220,000 | 0.0% | 5,073 | -12.5% | 0.00% | -50.0% |
| Q3 2018 | $220,000 | -46.3% | 5,797 | -36.1% | 0.00% | -33.3% |
| Q2 2018 | $410,000 | -13.0% | 9,075 | -6.9% | 0.00% | 0.0% |
| Q1 2018 | $471,000 | +9.3% | 9,750 | -11.0% | 0.00% | 0.0% |
| Q4 2017 | $431,000 | +1131.4% | 10,958 | +414.9% | 0.00% | – |
| Q2 2016 | $35,000 | +94.4% | 2,128 | +90.0% | 0.00% | – |
| Q1 2016 | $18,000 | -35.7% | 1,120 | +30.2% | 0.00% | – |
| Q4 2015 | $28,000 | – | 860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |